纳利类可以增强大鼠对诺亚上腺素的心脏缩反应
Danfeng Jiang1, Minami Matsuzaki1, Takanori Ida1
1Frontier Science Research Center, University of Miyazaki Faculty of Medicine, Miyazaki 889-1692, Japan.
Peptides
|June 1, 2023
概括
当与诺亚上腺素 (NA) 结合时,心房和C型尿性 (ANP和CNP) 意外地使大鼠的心脏缩恶化. 这挑战了尿素在心脏病中的假定保护作用.
科学领域:
- 心血管生理学心血管生理学
- 内分泌学 在内分泌学.
- 分子心脏病学分子心脏病学
背景情况:
- 交感神经系统过度激活会导致心血管损伤,包括心脏缩.
- 人们普遍认为,尿素 (NP) 能保护心脏免受缩和纤维化.
研究的目的:
- 为了研究心房 natriuretic (ANP) 和C型 natriuretic (CNP) 对大鼠的诺亚上腺素 (NA) 诱导的心脏缩的影响.
- 为了确定NP是否加剧或减轻心脏缩反应.
主要方法:
- 雄性Wistar大鼠接受了连续的皮下注射NA (30微克/小时) 随着或没有静脉注射ANP或CNP (1.0微克/小时) 14天.
- 使用放射测距法监测血压.
- 用心脏重量/体重比和左心室肌细胞大小来评估心脏缩.
主要成果:
- 输入NA增加了血压,并诱导轻度心脏缩.
- 与单独的NA相比,ANP或CNP与NA的同时使用显著增强了心脏缩.
- 在接受NA注入的老鼠中,ANP和CNP没有显著影响血压.
- 普拉佐辛或阿提诺洛尔治疗减弱了ANP增强的心脏缩.
结论:
- 在大鼠中,ANP和CNP都会增强诺亚上腺素对心脏的高效应.
- 这些发现表明,在特定条件下,心脏中尿素的潜在益增多作用.
- 这些结果挑战了NP的传统观点,即NP仅仅是高的心脏保护剂.
相关概念视频
01:29Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
471
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
471
01:22Heart Failure Drugs: Diuretics
430
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
430
01:17Antihypertensive Drugs: Action of β1 Blockers
494
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
494
01:17Hormonal Regulation of Blood Pressure
2.7K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.7K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
710
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
710